By Professor Susan Jane Connor

Journal articles

Kayes T; Bonnichsen M; Willmann L; Lorenzo A; Das A; El-Haddad C; Househ Z; Ng W; Ng W; Williams AJ; Prince D; Connor SJ, 2021, 'Menetrier's disease exacerbating ulcerative colitis and relieved by gastrectomy', BMJ Open Gastroenterology, 8, http://dx.doi.org/10.1136/bmjgast-2021-000806

Williams AJ; Karimi N; Chari R; Connor S; De Vera MA; Dieleman LA; Hansen T; Ismond K; Khurana R; Kingston D; O’Connor K; Sadowski DC; Fang-Hwa F; Wine E; Leung Y; Huang V, 2021, 'Shared decision making in pregnancy in inflammatory bowel disease: design of a patient orientated decision aid', BMC Gastroenterology, 21, http://dx.doi.org/10.1186/s12876-021-01853-y

Karimi N; Sechi AJ; Harb M; Sawyer E; Williams AJ; Ng W; Connor SJ, 2021, 'The effect of a nurse-led advice line and virtual clinic on inflammatory bowel disease service delivery: An Australian study', European Journal of Gastroenterology and Hepatology, 33, pp. E771 - E776, http://dx.doi.org/10.1097/MEG.0000000000002249

Dubinsky MC; Watanabe K; Molander P; Peyrin-Biroulet L; Rubin M; Melmed GY; Deuring JJ; Woolcott J; Cappelleri JC; Steinberg K; Connor S, 2021, 'Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living with Ulcerative Colitis-Patients' and Physicians' View', Inflammatory Bowel Diseases, 27, pp. 1747 - 1755, http://dx.doi.org/10.1093/ibd/izab016

Connor SJ; Sechi A; Andrade M; Deuring JJ; Witcombe D, 2021, 'Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views', JGH Open, 5, pp. 1033 - 1040, http://dx.doi.org/10.1002/jgh3.12627

Karimi N; Kanazaki R; Lukin A; Moore AR; Williams AJ; Connor S, 2021, 'Clinical communication in inflammatory bowel disease: A systematic review of the study of clinician-patient dialogue to inform research and practice', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2021-051053

Wu Y; Wen A; Selvanderan SP; Xuan W; Andrews JM; Koo JH; Williams AJ; Ng W; Connor S, 2021, 'Management Decisions in Crohn's Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels', Crohn S and Colitis 360, 3, http://dx.doi.org/10.1093/crocol/otab042

Gu B; De Gregorio M; Pipicella JL; Vande Casteele N; Andrews JM; Begun J; Connell W; D'Souza B; Gholamrezaei A; Hart A; Liew D; Radford-Smith G; Rimola J; Sutherland T; Toong C; Woods R; Wu Y; Xuan W; Williams AJ; Ng W; Ding NS; Connor S, 2021, 'Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol', BMJ open, 11, http://dx.doi.org/10.1136/bmjopen-2020-043921

Kaazan P; Li T; Seow W; Bednarz J; Pipicella J; Ng W; Wiiliams AJ; Connor S; Andrews J, 2021, 'P232 Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease', Journal of Crohn's and Colitis, 15, pp. S281 - S281, http://dx.doi.org/10.1093/ecco-jcc/jjab076.358

De Gregorio M; Lee T; Krishnaprasad K; Amos G; An YK; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor S; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Thompson A; Welman CJ; Yong EX; De Cruz P; van Langenberg D; Sparrow co-lead senior author M; Ding NS, 2021, 'P399 Higher anti-tumour necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulising Crohn’s disease: A retrospective multi-centre study', Journal of Crohn's and Colitis, 15, pp. S408 - S409, http://dx.doi.org/10.1093/ecco-jcc/jjab076.523

Wu Y; Lin B; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Williams AJ; Ng W; Connor S, 2021, 'Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost-savings', Internal Medicine Journal, 51, pp. 739 - 745, http://dx.doi.org/10.1111/imj.14644

Mohsen W; Williams AJ; Wark G; Sechi A; Koo JH; Xuan W; Bassan M; Ng W; Connor S, 2021, 'Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?', World Journal of Gastroenterology, 27, pp. 1090 - 1100, http://dx.doi.org/10.3748/wjg.v27.i11.1090

Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G, 2021, 'Australia IBD Microbiome (AIM) Study: Protocol for a multicentre longitudinal prospective cohort study', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2020-042493

Kim AH; Girgis A; De Cruz P; Siegel CA; Karimi N; Ruban SO; Sechi AJ; Watson Ng WS; Andrews JM; Connor SJ, 2021, 'Development and feasibility of a web-based decision aid for patients with ulcerative colitis: Qualitative pilot study', Journal of Medical Internet Research, 23, http://dx.doi.org/10.2196/15946

Kaazan P; Li T; Seow W; Bednarz J; Pipicella JL; Krishnaprasad K; Ng W; Williams A-J; Connor SJ; Andrews JM, 2021, 'Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease', JGH OPEN, 5, pp. 1063 - 1070, http://dx.doi.org/10.1002/jgh3.12631

Connor S, 2021, 'Biologics in IBD', Pathology, 53, pp. S16 - S16, http://dx.doi.org/10.1016/j.pathol.2021.05.057

Connor S, 2021, 'Biologics in IBD', Pathology, 53, pp. S5 - S5, http://dx.doi.org/10.1016/j.pathol.2021.05.017

Prentice RE; Rentsch C; Al-Ani AH; Zhang E; Johnson D; Halliday J; Bryant R; Begun J; Ward MG; Lewindon PJ; Connor SJ; Ghaly S; Christensen B, 2021, 'SARS-CoV-2 vaccination in patients with inflammatory bowel disease.', GastroHep, 3, pp. 212 - 228, http://dx.doi.org/10.1002/ygh2.473

Sam MJ; Connor SJ; Ng WWS; Toong CML, 2020, 'Comparative Evaluation of 4 Commercially Available ELISA Kits for Measuring Adalimumab and Anti-adalimumab Antibodies', Therapeutic Drug Monitoring, 42, pp. 821 - 828, http://dx.doi.org/10.1097/FTD.0000000000000795

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor S; Radford-Smith G; Andrews JM, 2020, 'Crohn’s Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease', Scandinavian Journal of Gastroenterology, 55, pp. 1419 - 1426, http://dx.doi.org/10.1080/00365521.2020.1839960

Karimi N; Moore AR; Lukin A; Kanazaki R; Williams AJ; Connor S, 2020, 'Clinical communication in inflammatory bowel disease: A systematic literature review protocol', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2020-039503

Reddy Pulusu SS; Srinivasan A; Krishnaprasad K; Cheng D; Begun J; Keung C; Van Langenberg D; Thin L; Mogilevski T; de Cruz P; Radford-Smith G; Flanagan E; Bell S; Kashkooli S; Sparrow M; Ghaly S; Bampton P; Sawyer E; Connor S; Rizvi QUA; Andrews JM; Mahy G; Chivers P; Travis S; CraigLawrance I, 2020, 'Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford', World Journal of Gastroenterology, 26, pp. 4428 - 4441, http://dx.doi.org/10.3748/WJG.V26.I30.4428

Kim AH; Girgis A; Karimi N; Sechi AJ; Descallar J; Andrews JM; Siegel CA; Connor SJ, 2020, 'A web-based decision aid (myAID) to enhance quality of life, empowerment, decision making, and disease control for patients with ulcerative colitis: Protocol for a cluster randomized controlled trial', Jmir Research Protocols, 9, http://dx.doi.org/10.2196/15994

Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B, 2020, 'Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty', Internal Medicine Journal, 50, pp. 798 - 804, http://dx.doi.org/10.1111/imj.14889

Gardiner FW; Bishop L; McMahon K; Nwose EU; Connor S; Begun J; Andrews JM, 2020, 'Aeromedical retrievals for gastrointestinal disorders in rural and remote Australia: the need for improved access to specialist advice', Internal Medicine Journal, 50, pp. 619 - 623, http://dx.doi.org/10.1111/imj.14822

Haifer C; Kelly CR; Paramsothy S; Andresen D; Papanicolas LE; McKew GL; Borody TJ; Kamm M; Costello SP; Andrews JM; Begun J; Chan HT; Connor S; Ghaly S; Johnson PDR; Lemberg DA; Paramsothy R; Redmond A; Sheorey H; Van Der Poorten D; Leong RW, 2020, 'Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice', Gut, 69, pp. 801 - 810, http://dx.doi.org/10.1136/gutjnl-2019-320260

Benson MJ; Abelev SV; Corte CJ; Connor SJ; McGregor IS, 2020, 'Attitudes and knowledge of australian gastroenterologists around the use of medicinal cannabis for inflammatory bowel disease', Crohn's and Colitis 360, 2, http://dx.doi.org/10.1093/crocol/otaa045

Benson MJ; Abelev SV; Connor SJ; Corte CJ; Martin LJ; Gold LK; Suraev AS; McGregor IS, 2020, 'Medicinal cannabis for inflammatory bowel disease: A survey of perspectives, experiences, and current use in australian patients', Crohn S and Colitis 360, 2, http://dx.doi.org/10.1093/crocol/otaa015

Julsgaard M; Hvas CL; Gearry RB; Gibson PR; Fallingborg J; Sparrow MP; Bibby BM; Connell WR; Brown SJ; Kamm MA; Lawrance IC; Vestergaard T; Svenningsen L; Baekdal M; Kammerlander H; Walsh A; Boysen T; Bampton P; Radford-Smith G; Kjeldsen J; Andrews JM; Subramaniam K; Moore GT; Jensen NM; Connor SJ; Wildt S; Wilson B; Ellard K; Christensen LA; Bell SJ, 2020, 'Anti-TNF Therapy in Pregnant Women with Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes', Inflammatory Bowel Diseases, 26, pp. 93 - 102, http://dx.doi.org/10.1093/ibd/izz110

Flanagan E; Gibson PR; Wright EK; Moore GT; Sparrow MP; Connell W; Kamm MA; Begun J; Christensen B; De Cruz P; Shelton E; Dowling D; Andrews JM; Brown SJ; Niewiadomski O; Ward MG; Rosella O; Rosella G; Kiburg KV; Ross AL; Bell SJ; PICCOLO Study Group , 2020, 'Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure.', Aliment Pharmacol Ther, 52, pp. 1551 - 1562, http://dx.doi.org/10.1111/apt.16102

Gu B; Venkatesh K; Williams A-J; Ng W; Corte C; Simon G; Xuan W; Paramsothy S; Connor SJ, 2020, 'Sa1891 HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE', Gastroenterology, 158, http://dx.doi.org/10.1016/s0016-5085(20)31850-3

Little RD; Chu IE; Van Der Zanden EP; Flanagan E; Bell SJ; Gibson PR; Sparrow MP; Shelton E; Connor SJ; Roblin X; Ward MG, 2019, 'Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients with Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis', Journal of Crohn S and Colitis, 13, pp. 1527 - 1536, http://dx.doi.org/10.1093/ecco-jcc/jjz103

An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J, 2019, 'Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis', Medical Journal of Australia, 211, pp. 461 - 467, http://dx.doi.org/10.5694/mja2.50384

Kim AH; Girgis A; De Cruz P; Siegel CA; Karimi N; Ruban SO; Sechi AJ; Ng WSW; Andrews JM; Connor SJ, 2019, 'Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study (Preprint)', , http://dx.doi.org/10.2196/preprints.15946

Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO, 2019, 'Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis', Gastroenterology, 156, pp. 1440 - 1454.e2, http://dx.doi.org/10.1053/j.gastro.2018.12.001

Walker GJ; Harrison JW; Heap GA; Voskuil MD; Andersen V; Anderson CA; Ananthakrishnan AN; Barrett JC; Beaugerie L; Bewshea CM; Cole AT; Cummings FR; Daly MJ; Ellul P; Fedorak RN; Festen EAM; Florin TH; Gaya DR; Halfvarson J; Hart AL; Heerasing NM; Hendy P; Irving PM; Jones SE; Koskela J; Lindsay JO; Mansfield JC; McGovern D; Parkes M; Pollok RCG; Ramakrishnan S; Rampton DS; Rivas MA; Russell RK; Schultz M; Sebastian S; Seksik P; Singh A; So K; Sokol H; Subramaniam K; Todd A; Annese V; Weersma RK; Xavier R; Ward R; Weedon MN; Goodhand JR; Kennedy NA; Ahmad T; Holden AL; Andrews J; Auth M; Babu S; Bampton P; Banim P; Barnes T; Basude D; Beckly J; Bell A; Bell S; Bhandari P; Bloom S; Border D; Bredin F; Brookes MJ; Brown M; Calvert C; Campbell D; Chanchlani N; Chaudhary B; Chaudhary R; Chung-Faye G; Colleypriest B; Connor S; Cooney R; Cooper S; Creed TJ; Croft N; Cullen S; D'Amato M; D'Inca R; Dalal H; Daneshmend TK; Das D; Delaney M; DeSilva S; Dhar A; Dharmasiri S; Direkze N; Dunckley P; Elphick D; Everett SM; Feeney M; Fell J; Foley S; Franke A; Gavin D; Gee I, 2019, 'Association of Genetic Variants in NUDT15 with Thiopurine-Induced Myelosuppression in Patients with Inflammatory Bowel Disease', JAMA Journal of the American Medical Association, 321, pp. 753 - 761, http://dx.doi.org/10.1001/jama.2019.0709

Armuzzi A; Kayhan C; Panaccione R; Watanabe K; Molander P; Rubin DT; Peyrin-Biroulet L; Melmed G; Connor S; Colombel J-F; Dubinsky M, 2019, 'P005 DELAY IN DIAGNOSIS OF ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', Gastroenterology, 156, pp. S6 - S6, http://dx.doi.org/10.1053/j.gastro.2019.01.052

Schreiber S; Panaccione R; Kayhan C; Lopez-Sanroman A; Peyrin-Biroulet L; Armuzzi A; Dubinsky M; Melmed G; Rubin M; Connor S; Keefer L; Rubin DT, 2019, 'P023 PATIENT AND HEALTHCARE PROFESSIONAL VIEWS ON EMOTIONAL HEALTH AND INTIMACY IN ULCERATIVE COLITIS: RESULTS OF A GLOBAL ULCERATIVE COLITIS NARRATIVE SURVEY', Gastroenterology, 156, pp. S17 - S17, http://dx.doi.org/10.1053/j.gastro.2019.01.072

Liu F; Ma R; Tay CYA; Octavia S; Lan R; Chung HKL; Riordan SM; Grimm MC; Leong RW; Tanaka MM; Connor S; Zhang L, 2018, 'Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn's disease', Emerging Microbes and Infections, 7, pp. 1 - 14, http://dx.doi.org/10.1038/s41426-018-0065-6

Connor S, 2018, 'What can Australian Inflammatory Bowel Disease Association achieve in the next 3 to 5 years?', Journal of Gastroenterology and Hepatology Australia, 33, pp. 35, http://dx.doi.org/10.1111/jgh.14437

Paramsothy S; Kamm M; Nielsen S; Deshpande N; Faith J; Clemente J; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong R; Connor S; Ng W; Lin E; Wilkins M; Colombel J-F; Borody T; Mitchell H; Kaakoush N, 2018, 'OP019 In faecal microbiota transplantation (FMT) for ulcerative colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short-chain fatty acid production are associated with remission (FOCUS study)', Journal of Crohn's and Colitis, 12, pp. S013 - S014, http://dx.doi.org/10.1093/ecco-jcc/jjx180.018

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor S; Radford-Smith G; Andrews J, 2018, 'P328 Crohn’s colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD)', Journal of Crohn's and Colitis, 12, pp. S266 - S268, http://dx.doi.org/10.1093/ecco-jcc/jjx180.455

Little R; Chu I; van der Zanden E; Flanagan E; Bell S; Sparrow M; Shelton E; Connor S; Roblin X; Ward M, 2018, 'P709 Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis', Journal of Crohn's and Colitis, 12, pp. S469 - S470, http://dx.doi.org/10.1093/ecco-jcc/jjx180.836

Paramsothy S; Kamm MA; Nielsen S; Deshpande N; Faith J; Clemente JC; Paramsothy R; Walsh A; van den Bogaerde J; Samuel D; Leong RW; Connor SJ; Ng WSW; Lin E; Wilkins M; Colombel JF; Borody TJ; Mitchell HM; Kaakoush NO, 2018, '130 - In Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis, Fusobacterium is Associated with Lack of Remission, while Metabolic Shifts to Starch Degradation and Short Chain Fatty Acid Production are Associated with Remission – Results from the Randomized Controlled Focus Study', Gastroenterology, 154, pp. S - 35, http://dx.doi.org/10.1016/s0016-5085(18)30588-2

Little RD; Chu IE; van der Zanden E; Flanagan E; Bell S; Sparrow M; Shelton E; Connor SJ; Roblin X; Ward MG, 2018, 'Mo1883 - Is There a Difference in Adalimumab Drug Levels According to Pen vs. Syringe use - An International, Multicenter Retrospective Analysis', Gastroenterology, 154, http://dx.doi.org/10.1016/s0016-5085(18)32847-6

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; McMahon A; Connor SJ; Radford-Smith GL; Andrews JM, 2018, 'Tu1020 - Crohn's Colitis Care (CCcare) - Development and Testing of a Bespoke Cloud-Based Clinical Management System for Inflammatory Bowel Disease (IBD)', Gastroenterology, 154, pp. S - 892, http://dx.doi.org/10.1016/s0016-5085(18)33012-9

Lord A; Mortlock S; Montgomery G; Simms L; Krishnaprasad K; Hanigan K; Doecke JD; Gearry R; Lawrance I; Bampton PA; Andrews JM; Mahy G; Connor SJ; Sparrow M; Bell S; Walsh A; Radford-Smith GL, 2018, 'Tu1807 - Genetically Distinct Signatures of Mild and Severe Ulcerative Colitis', Gastroenterology, 154, pp. S - 1025, http://dx.doi.org/10.1016/s0016-5085(18)33433-4

Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW, 2017, 'Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases', Alimentary Pharmacology and Therapeutics, 46, pp. 1037 - 1053, http://dx.doi.org/10.1111/apt.14368

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011

Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ, 2017, 'The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus', Internal Medicine Journal, 47, pp. 1263 - 1269, http://dx.doi.org/10.1111/imj.13488

Back to profile page